Published in Transfus Med Rev on January 01, 2008
The hazards of blood transfusion in historical perspective. Blood (2008) 1.54
Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease. Lab Invest (2009) 1.48
Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. BMC Public Health (2008) 1.30
Human prion diseases in the United States. PLoS One (2010) 1.03
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One (2010) 1.00
Preclinical deposition of pathological prion protein in muscle of experimentally infected primates. PLoS One (2010) 0.91
Supportive care in patients with acute leukaemia: historical perspectives. Blood Transfus (2014) 0.76
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis (2012) 2.01
West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med (2005) 1.98
Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol (2006) 1.97
Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion (2008) 1.95
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr (2004) 1.84
Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J (2010) 1.78
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States. Transfusion (2009) 1.52
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion (2007) 1.43
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol (2013) 1.42
Age-related donor return patterns among first-time blood donors in the United States. Transfusion (2009) 1.40
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust (2010) 1.39
The public health impact of prion diseases. Annu Rev Public Health (2005) 1.33
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion (2009) 1.19
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology (2003) 1.19
Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J (2010) 1.17
Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med (2005) 1.15
Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people. Public Health Rep (2011) 1.10
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology (2005) 1.08
Changing age distribution of the blood donor population in the United States. Transfusion (2007) 1.08
Re: Examining the Association Between Kawasaki Disease and Pertussis. Epidemiology (2015) 1.07
Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol Metab (2011) 1.06
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis (2008) 1.05
Human prion diseases in the United States. PLoS One (2010) 1.03
Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J (2002) 1.02
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One (2010) 1.00
Kawasaki disease and human coronavirus. J Infect Dis (2005) 0.97
An evaluation of hospitalizations for Kawasaki syndrome in Georgia. Arch Pediatr Adolesc Med (2002) 0.97
Barriers to Creutzfeldt-Jakob disease autopsies, California. Emerg Infect Dis (2004) 0.96
Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein. J Biol Chem (2005) 0.96
Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis (2005) 0.94
Infectious disease hospitalizations among older American Indian and Alaska Native adults. Public Health Rep (2007) 0.92
Kawasaki syndrome hospitalizations in Ireland, 1996 through 2000. Pediatr Infect Dis J (2003) 0.92
Highly sensitive TaqMan RT-PCR assay for detection and quantification of both lineages of West Nile virus RNA. J Clin Virol (2006) 0.92
Guillain-barré syndrome following influenza vaccination: causal or coincidental? Curr Infect Dis Rep (2011) 0.88
Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. Transfusion (2007) 0.88
Barriers to autopsy: Creutzfeldt-Jakob disease in New York state. Neuroepidemiology (2006) 0.88
Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.88
Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Clin Lab Med (2002) 0.86
Genetic analysis of West Nile virus isolates from US blood donors during 2002-2005. J Clin Virol (2008) 0.86
Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis (2015) 0.86
Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion (2009) 0.85
Creutzfeldt-Jakob disease in recipients of corneal transplants. Cornea (2008) 0.84
Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005. Neuroepidemiology (2010) 0.83
Implementation of the Uniform Donor History Questionnaire across the American Red Cross Blood Services: increased deferral among repeat presenters but no measurable impact on blood safety. Transfusion (2007) 0.82
An investigation of potential neurosurgical transmission of Creutzfeldt-Jakob disease: challenges and lessons learned. Infect Control Hosp Epidemiol (2006) 0.81
Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries. Emerg Infect Dis (2012) 0.81
Disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol (2010) 0.81
Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark. Acta Paediatr (2013) 0.80
Hospital charges attributable to a primary diagnosis of infectious diseases in older adults in the United States, 1998 to 2004. J Am Geriatr Soc (2008) 0.79
Transmissible spongiform encephalopathies. J Am Vet Med Assoc (2008) 0.79
Variant Creutzfeldt-Jakob disease death, United States. Emerg Infect Dis (2005) 0.79
Travel history, hunting, and venison consumption related to prion disease exposure, 2006-2007 FoodNet Population Survey. J Am Diet Assoc (2011) 0.79
A method for estimating incidence rate of infectious diseases among first-time blood donors. Transfusion (2008) 0.78
Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone. Emerg Infect Dis (2013) 0.77
Kawasaki disease hospitalization rate among children younger than 5 years in California, 2003-2010. Pediatr Infect Dis J (2014) 0.77
Kawasaki syndrome hospitalizations and associated costs in the United States. Public Health Rep (2003) 0.76
On residual risk assessment for first-time donation. Transfusion (2007) 0.75
Etymologia: prion. Emerg Infect Dis (2012) 0.75
Clinical assessment of self-reported acute flaccid paralysis in a population-based setting in Guatemala. Am J Trop Med Hyg (2010) 0.75
Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report. BMC Neurol (2011) 0.75
Reply: To PMID 22565293. Pediatr Infect Dis J (2013) 0.75
Sporadic fatal insomnia in an adolescent. Pediatrics (2014) 0.75
Reply to Smyth et al. Infect Control Hosp Epidemiol (2014) 0.75
Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines. BMJ (2011) 0.75
Performance of two triplex nucleic acid test systems. Transfusion (2010) 0.75
Intracranial Procedures and Expected Frequency of Creutzfeldt-Jakob Disease. Neuroepidemiology (2015) 0.75
Investigation of a possible iatrogenic case of Creutzfeldt-Jakob disease after a neurosurgical procedure. Infect Control Hosp Epidemiol (2006) 0.75
A case of Creutzfeldt-Jakob disease associated with a dura mater graft in the United States. Infect Control Hosp Epidemiol (2007) 0.75